Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing

Nucleic Acids Research

Volumn 37, Issue 19, 2009, Pages 6515-6527

  Nojima, Takayuki ^a   Oshiro Ideue, Takako ^a   Nakanoya, Hiroto ^a   Kawamura, Hidenobu ^a   Morimoto, Tomomi ^b   Kawaguchi, Yasushi ^b   Kataoka, Naoyuki ^a   Hagiwara, Masatoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MESSENGER RNA PRECURSOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN ICP27; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 2; INTRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; REPORTER GENE; VIRUS REPLICATION;

CELL LINE; GENES, REPORTER; HERPESVIRUS 2, HUMAN; HUMANS; INTRONS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RNA; RNA PRECURSORS; RNA SPLICE SITES; RNA SPLICING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 2;

EID: 71049151501     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp633     Document Type: Article

References (65)

1. Johnson,J.M., Castle,J., Garrett-Engele,P., Kan,Z., Loerch,P.M., Armour,C.D., Santos,R., Schadt,E.E., Stoughton,R. and Shoemaker,D.D. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science, 302, 2141-2144.
2. Blencowe,B.J. (2006) Alternative splicing: New insights from global analyses. Cell, 126, 37-47.
3. Black,D.L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem., 72, 291-336.
4. Matlin,A.J., Clark,F. and Smith,C.W. (2005) Understanding alternative splicing: Towards a cellular code. Nat. Rev. Mol. Cell Biol., 6 386-398.
5. Schwartz,S., Felber,B.K., Fenyo,E.M. and Pavlakis,G.N. (1990) Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol., 64, 5448-5456.
6. Stoltzfus,C.M. and Madsen,J.M. (2006) Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr. HIV Res., 4, 43-55.
7. Long,J.C. and Caceres,J.F. (2009) The SR protein family of splicing factors: Master regulators of gene expression. Biochem. J., 417 15-27.
8. Lin,S. and Fu,X.D. (2007) SR proteins and related factors in alternative splicing. Adv. Exp. Med. Biol., 623, 107-122.
9. Kanopka,A., Muhlemann,O., Petersen-Mahrt,S., Estmer,C., Ohrmalm,C. and Akusjarvi,G. (1998) Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature, 393, 185-187.
10. Fukuhara,T., Hosoya,T., Shimizu,S., Sumi,K., Oshiro,T., Yoshinaka,Y., Suzuki,M., Yamamoto,N., Herzenberg,L.A., Herzenberg,L.A. et al. (2006) Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl Acad. Sci. USA, 103, 11329-11333.
11. Ishov,A.M. and Maul,G.G. (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol., 134, 815-826.
12. de The,H., Lavau,C., Marchio,A., Chomienne,C., Degos,L. and Dejean,A. (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
13. Kakizuka,A., Miller,W.H. Jr., Umesono,K., Warrell,R.P. Jr., Frankel,S.R., Murty,V.V., Dmitrovsky,E. and Evans,R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674.
14. Goddard,A.D., Borrow,J., Freemont,P.S. and Solomon,E. (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science, 254, 1371-1374.
15. Gurrieri,C., Capodieci,P., Bernardi,R., Scaglioni,P.P., Nafa,K., Rush,L.J., Verbel,D.A., Cordon-Cardo,C. and Pandolfi,P.P. (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst., 96, 269-279.
16. Terris,B., Baldin,V., Dubois,S., Degott,C., Flejou,J.F., Henin,D. and Dejean,A. (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55, 1590-1597.
17. Koken,M.H., Linares-Cruz,G., Quignon,F., Viron,A., Chelbi-Alix,M.K., Sobczak-Thepot,J., Juhlin,L., Degos,L., Calvo,F. and de The,H. (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene, 10, 1315-1324.
18. Condemine,W., Takahashi,Y., Zhu,J., Puvion-Dutilleul,F., Guegan,S., Janin,A. and de The,H. (2006) Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res., 66, 6192-6198.
19. Salomoni,P. and Pandolfi,P.P. (2002) The role of PML in tumor suppression. Cell, 108, 165-170.
20. Zhong,S., Salomoni,P. and Pandolfi,P.P. (2000) The transcriptional role of PML and the nuclear body. Nat. Cell Biol, 2, E85-E90.
21. Hofmann,T.G. and Will,H. (2003) Body language: The function of PML nuclear bodies in apoptosis regulation. Cell Death Differ., 10 1290-1299.
22. Guo,A., Salomoni,P., Luo,J., Shih,A., Zhong,S., Gu,W. and Pandolfi,P.P. (2000) The function of PML in p53-dependent apoptosis. Nat. Cell Biol., 2, 730-736.
23. Dellaire,G. and Bazett-Jones,D.P. (2004) PML nuclear bodies: Dynamic sensors of DNA damage and cellular stress. Bioessays, 26, 963-977.
24. Ching,R.W., Dellaire,G., Eskiw,C.H. and Bazett-Jones,D.P. (2005) PML bodies: A meeting place for genomic loci? J. Cell Sci., 118, 847-854.
25. Pearson,M., Carbone,R., Sebastiani,C., Cioce,M., Fagioli,M., Saito,S., Higashimoto,Y., Appella,E., Minucci,S., Pandolfi,P.P. et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 406, 207-210.
26. Wang,Z.G., Delva,L., Gaboli,M., Rivi,R., Giorgio,M., Cordon-Cardo,C., Grosveld,F. and Pandolfi,P.P. (1998) Role of PML in cell growth and the retinoic acid pathway. Science, 279, 1547-1551.
27. Lin,H.K., Bergmann,S. and Pandolfi,P.P. (2004) Cytoplasmic PML function in TGF-beta signalling. Nature, 431, 205-211.
28. Everett,R.D. (2001) DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene, 20, 7266-7273.
29. Regad,T. and Chelbi-Alix,M.K. (2001) Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene, 20 7274-7286.
30. Chee,A.V., Lopez,P., Pandolfi,P.P. and Roizman,B. (2003) Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol., 77, 7101-7105.
31. Maul,G.G., Ishov,A.M. and Everett,R.D. (1996) Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology, 217, 67-75.
32. Jensen,K., Shiels,C. and Freemont,P.S. (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene, 20, 7223-7233.
33. Nisole,S., Stoye,J.P. and Saib,A. (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev., 3, 799-808.
34. Condemine,W., Takahashi,Y., Le Bras,M. and de The,H. (2007) A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J. Cell Sci., 120, 3219-3227.
35. Kuroyanagi,H., Kobayashi,T., Mitani,S. and Hagiwara,M. (2006) Transgenic alternative-splicing reporters reveal tissue-specific expression profiles and regulation mechanisms in vivo. Nat. Methods, 3, 909-915.
36. Ohno,G., Hagiwara,M. and Kuroyanagi,H. (2008) STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo. Genes Dev., 22, 360-374.
37. Tanaka,M., Kagawa,H., Yamanashi,Y., Sata,T. and Kawaguchi,Y. (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: Viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol., 77, 1382-1391.
38. Sugimoto,K., Uema,M., Sagara,H., Tanaka,M., Sata,T., Hashimoto,Y. and Kawaguchi,Y. (2008) Simultaneous tracking of capsid, tegument, and envelope protein localization in living cells infected with triply fluorescent herpes simplex virus 1. J. Virol., 82, 5198-5211.
39. Tanaka,M., Kodaira,H., Nishiyama,Y., Sata,T. and Kawaguchi,Y. (2004) Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect./ Institut Pasteur, 6, 485-493.
40. Krainer,A.R., Maniatis,T., Ruskin,B. and Green,M.R. (1984) Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell, 36, 993-1005.
41. Strom,T. and Frenkel,N. (1987) Effects of herpes simplex virus on mRNA stability. J. Virol., 61, 2198-2207.
42. Rice,S.A. and Lam,V. (1994) Amino acid substitution mutations in the herpes simplex virus ICP27 protein define an essential gene regulation function. J. Virol., 68, 823-833.
43. Soliman,T.M. and Silverstein,S.J. (2000) Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways. J. Virol. 74, 2814-2825.
44. Sedlackova,L., Perkins,K.D., Lengyel,J., Strain,A.K., van Santen,V.L. and Rice,S.A. (2008) Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism. J. Virol., 82, 7443-7455.
45. Majerciak,V., Yamanegi,K., Allemand,E., Kruhlak,M., Krainer,A.R. and Zheng,Z.M. (2008) Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J. Virol., 82, 2792-2801.
46. Wu,S., Romfo,C.M., Nilsen,T.W. and Green,M.R. (1999) Functional recognition of the 3′ splice site AG by the splicing factor U2AF35. Nature, 402, 832-835.
47. Sacks,W.R., Greene,C.C., Aschman,D.P. and Schaffer,P.A. (1985) Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol., 55, 796-805.
48. Rice,S.A. and Knipe,D.M. (1988) Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J. Virol., 62, 3814-3823.
49. Sandri-Goldin,R.M. and Hibbard,M.K. (1996) The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction. J. Virol., 70, 108-118.
50. Sciabica,K.S., Dai,Q.J. and Sandri-Goldin,R.M. (2003) ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J., 22, 1608-1619.
51. Bryant,H.E., Wadd,S.E., Lamond,A.I., Silverstein,S.J. and Clements,J.B. (2001) Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J. Virol., 75, 4376-4385.
52. Sokolowski,M., Scott,J.E., Heaney,R.P., Patel,A.H. and Clements,J.B. (2003) Identification of herpes simplex virus RNAs that interact specifically with regulatory protein ICP27 in vivo. J. Biol. Chem. 278, 33540-33549.
53. Verma,D. and Swaminathan,S. (2008) Epstein-Barr virus SM protein functions as an alternative splicing factor. J. Virol., 82, 7180-7188.
54. Phelan,A. and Clements,J.B. (1997) Herpes simplex virus type 1 immediate early protein IE63 shuttles between nuclear compartments and the cytoplasm. J. Gen. Virol., 78(Pt 12), 3327-3331.
55. Mears,W.E. and Rice,S.A. (1998) The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm. Virology, 242, 128-137.
56. Hiriart,E., Farjot,G., Gruffat,H., Nguyen,M.V., Sergeant,A. and Manet,E. (2003) A novel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein. J. Biol. Chem., 278, 335-342.
57. Malik,P., Blackbourn,D.J. and Clements,J.B. (2004) The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J. Biol. Chem., 279, 33001-33011.
58. Williams,B.J., Boyne,J.R., Goodwin,D.J., Roaden,L., Hautbergue,G.M., Wilson,S.A. and Whitehouse,A. (2005) The prototype gamma-2 herpesvirus nucleocytoplasmic shuttling protein, ORF 57, transports viral RNA through the cellular mRNA export pathway. Biochem. J., 387, 295-3
59. Lischka,P., Toth,Z., Thomas,M., Mueller,R. and Stamminger,T. (2006) The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/ H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA. Mol. Cell Biol., 26, 1631-1643.
60. Soliman,T.M., Sandri-Goldin,R.M. and Silverstein,S.J. (1997) Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J. Virol., 71, 9188-9197.
61. Koffa,M.D., Clements,J.B., Izaurralde,E., Wadd,S., Wilson,S.A., Mattaj,I.W. and Kuersten,S. (2001) Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway. EMBO J., 20, 5769-5778.
62. Fogal,V., Gostissa,M., Sandy,P., Zacchi,P., Sternsdorf,T., Jensen,K., Pandolfi,P.P., Will,H., Schneider,C. and Del Sal,G. (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J., 19, 6185-6195.
63. Alcalay,M., Tomassoni,L., Colombo,E., Stoldt,S., Grignani,F., Fagioli,M., Szekely,L., Helin,K. and Pelicci,P.G. (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell Biol., 18, 1084-1093.
64. Doucas,V., Ishov,A.M., Romo,A., Juguilon,H., Weitzman,M.D., Evans,R.M. and Maul,G.G. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev., 10, 196-207.
65. Hoppe,A., Beech,S.J., Dimmock,J. and Leppard,K.N. (2006) Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J. Virol., 80, 3042-3049.